The treatment of inflammatory disorders and pain using betaaminoalcohols

Details for Australian Patent Application No. 2005224160 (hide)

Owner Sosei R&D Ltd.

Inventors Baxter, Andrew Douglas; Brew, John

Agent FB Rice

Pub. Number AU-A-2005224160

PCT Pub. Number WO2005/089741

Priority 0406016.6 17.03.04 GB; 0418556.7 19.08.04 GB; 0422880.5 14.10.04 GB

Filing date 17 March 2005

Wipo publication date 29 September 2005

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/089741 Priority application(s): WO2005/089741

11 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224162-Emulsifier composition for shortening

2005224159-Pharmaceutical composition comprising a benzodiazepine derivative and a inhibitor of the RSV fusion protein